Levels of DHA in the Blood
Conditions
Brief summary
The clinical trial will provide a milk-based drink with constant amounts of nutrients but differing amount of Docosahexaenoic Acid (DHA).
Interventions
OTHERNutritional beverage
Sponsors
Mead Johnson Nutrition
Eligibility
Sex/Gender
ALL
Age
18 Months to 36 Months
Healthy volunteers
Yes
Inclusion criteria
* Participant is 18 to 36 months of age * Participant's current weight and height within the 10th to 90th percentiles * Parent/caregiver reports that participant consumes milk or a milk-based beverage on a daily basis * Participant lives at home with parent(s) or other family member(s) * Signed informed consent and authorization obtained to use and or disclose Protected Health Information (PHI)
Exclusion criteria
* Participant who is receiving any breast milk at time of randomization * Participant with an active infection. * Participant with a history of underlying disease, chronic disease, or congenital malformation which in the opinion of the Investigator is likely to interfere with the evaluation of the participant. * Known or suspected intolerance to cow's milk protein * Participant diagnosed with diabetes * Participant is from a multiple birth and the sibling(s) are still living * Participant with a sibling that has participated in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood lipid levels of Docosahexaenoic Acid (DHA) at enrollment and after two months, assessment of usual DHA intake, and product acceptability and use | — |
Secondary
| Measure | Time frame |
|---|---|
| Growth | — |
| Determination of nutrient status, including iron and vitamin D status | — |
| Adverse Events | — |
Countries
United States
Outcome results
None listed